Enzo Biochem, Inc.
(NYSE : ENZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$838.74m
AMGNAmgen Inc.
0.89%188.341.2%$621.82m
GILDGilead Sciences, Inc.
1.84%67.590.9%$512.40m
BIIBBiogen Inc.
2.51%332.871.3%$445.54m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$305.14m
ILMNIllumina, Inc.
2.51%299.823.5%$302.67m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$269.75m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$233.68m
LOXOLoxo Oncology Inc
-0.03%234.6612.7%$170.39m
SRPTSarepta Therapeutics, Inc.
2.65%138.4515.4%$148.57m
AAgilent Technologies, Inc.
1.64%78.281.6%$133.87m
INCYIncyte Corporation
0.88%84.152.5%$132.72m
EXASExact Sciences Corporation
0.49%88.5525.3%$128.36m
ARRYArray BioPharma Inc.
4.95%23.138.2%$105.79m
EXELExelixis, Inc.
-0.18%22.266.4%$97.74m

Company Profile

Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.